Mitochondria and Cancer
From Basic Science to Clinical Applications – Understanding Pathogenesis, Therapy Resistance, and Disease Relapse
- 1st Edition - January 12, 2026
- Imprint: Elsevier
- Editors: Farhad Taghizadeh-Hesary, Sumel Ashique, Babak Behnam, Maria Vliora
- Language: English
- Paperback ISBN:9 7 8 - 0 - 4 4 3 - 4 0 5 3 5 - 8
- eBook ISBN:9 7 8 - 0 - 4 4 3 - 4 0 5 3 6 - 5
Mitochondria and Cancer: From Basic Science to Clinical Applications – Understanding Pathogenesis, Therapy Resistance, and Disease Relapse is an essential reference for understa… Read more
Purchase options
Mitochondria and Cancer: From Basic Science to Clinical Applications – Understanding Pathogenesis, Therapy Resistance, and Disease Relapse is an essential reference for understanding the intricate relationship between mitochondria and cancer. The book explores cancer pathogenesis, therapy resistance, and disease relapse, all of which are significantly influenced by mitochondrial metabolism. Written for oncology researchers, it combines fundamental scientific knowledge with clinical relevance, providing recent findings and practical recommendations for cancer prevention and prognosis. This comprehensive guide covers the tumor microenvironment, cancer stem cells, microbiota, and resistance mechanisms while addressing novel topics like mitochondria-enhancing strategies and targeted therapies. With contributions from global experts, the book offers a well-rounded view of current research, making it a valuable resource for anyone in cancer biology or molecular biology fields.
- Combines fundamental scientific knowledge with clinical relevance, covering a wide array of topics from mitochondrial metabolism to innovative therapeutic strategies
- Features unique topics such as applying magnetic fields to target mitochondria, offering cutting-edge approaches to cancer treatment and management
- Includes contributions from experts across different countries and institutions, providing a well-rounded, global view of current research in mitochondrial involvement in cancer
Researchers in oncology, molecular biology, clinical oncology, and biomedical research
1. Mitochondria: Origin, Structure, and Function
2. Mitochondrial Metabolism and Trafficking in Cancer
3. Mitochondrial Genome and Cancer
4. Mitochondrial-nuclear Crosstalk and Its Role in Cancer
5. Mitochondria and Tumor Microenvironment
6. Mitochondria and Cancer Stem Cells
7. Mitochondria, Exosome, Cancer
8. Mitochondria, Microbiota, Cancer
9. MiRNAs and Their Impacts on Cancer Cell’s Mitochondria
10. Mitochondria and Cancer Prevention
11. Mitochondria and Cancer Diagnosis
12. Mitochondrial Metabolism as a Prognostic Biomarker (Mitochondria and Cancer Progression)
13. Mitochondria, Tumor Microenvironment, and Radioresistance
14. Mitochondria and Resistance to Chemotherapy
15. Mitochondria and Resistance to Targeted Therapies
16. Mitochondria and Resistance to Immunotherapy
17. Mitochondria Enhancing Strategies in Cancer
18. Advances in Targeted Anti-mitochondrial Therapies
19. Applying Magnetic Fields to Target Mitochondria
2. Mitochondrial Metabolism and Trafficking in Cancer
3. Mitochondrial Genome and Cancer
4. Mitochondrial-nuclear Crosstalk and Its Role in Cancer
5. Mitochondria and Tumor Microenvironment
6. Mitochondria and Cancer Stem Cells
7. Mitochondria, Exosome, Cancer
8. Mitochondria, Microbiota, Cancer
9. MiRNAs and Their Impacts on Cancer Cell’s Mitochondria
10. Mitochondria and Cancer Prevention
11. Mitochondria and Cancer Diagnosis
12. Mitochondrial Metabolism as a Prognostic Biomarker (Mitochondria and Cancer Progression)
13. Mitochondria, Tumor Microenvironment, and Radioresistance
14. Mitochondria and Resistance to Chemotherapy
15. Mitochondria and Resistance to Targeted Therapies
16. Mitochondria and Resistance to Immunotherapy
17. Mitochondria Enhancing Strategies in Cancer
18. Advances in Targeted Anti-mitochondrial Therapies
19. Applying Magnetic Fields to Target Mitochondria
- Edition: 1
- Published: January 12, 2026
- Imprint: Elsevier
- Language: English
FT
Farhad Taghizadeh-Hesary
Dr. Farhad Taghizadeh-Hesary is an economics and finance associate professor at Tokai University in Japan. He is the co-founder and vice president of the International Society for Energy Transition Studies (ISETS), Editor-in-Chief of the Journal of Environmental Assessment Policy and Management (World Scientific), and associate editor of several academic journals. He has authored over 350 peer-reviewed journal papers and book chapters and edited 25 books by major publishers in various fields, including green finance and sustainability, energy economics, and policy. He was included on Clarivate’s list of Highly Cited Researchers. In 2023, he received the Commendation and Medal for Science and Technology from the Minister of Education, Culture, Sports, Science, and Technology of Japan for his outstanding research achievements. He holds a Ph.D. in economics from Keio University, Japan.
Affiliations and expertise
Associate Professor of Economics and Finance at the Tokai Research Institute for Environment and Sustainability, Tokai University, Japan. He also serves as the Vice President of the International Society for Energy Transition Studies.SA
Sumel Ashique
Sumel Ashique has been working as an assistant professor at Bengal College of Pharmaceutical Sciences & Research, Durgapur 713212, West Bengal, India, West Bengal, India. He has 3.5 years of teaching experience. He has achieved 70+ publications of International and national accredited reputed journals (Scopus, UGC). He has knowledge in drug delivery, nanotechnology and targeted treatment strategy. He has also 6 granted patents from IP and Australia & 20 book chapters have been submitted to well-known publishers like Springer, Elsevier, Bentham and Taylor & Francis. Currently he is editing 13 books under CRC Press, Taylor & Francis, Springer and Wiley.
Affiliations and expertise
Asst. Professor, Department of Pharmaceutical Technology, Bharat Technology, Uluberia, West Bengal, IndiaBB
Babak Behnam
Dr. Babak Behnam has completed his PhD degree at the University College London (UCL) in Human Genetics. Then he served as postdoctoral research fellow at the University of Michigan School of Medicine and University of Central Florida (UCF). He joined the Undiagnosed Disease Program (UDP) at NIH while doing an American Board of Medical Genetics and Genomic in clinical biochemical laboratory genetics at NHGRI, NIH. He joined NSF International as a clinical research organization. Dr. Behnam has published more than 70 peer-reviewed papers and has nine patents to his name throughout his career; also, has served as an Editorial Board Member of several scientific journals. He has enthusiasm in translational research, neuroscience & neurogenetics, and biochemical & molecular mechanisms utilizing advanced technological improvements in biochemical genetics, genomics, and NGS platforms. Also, he has an experience and interest in clinical research, and regulatory and scientific analysis of clinical trials.
Affiliations and expertise
American University, College of Arts and Sciences, Department of Biology, Washington, DC, USA; Avicenna Biotech research, Clarksburg, MD, USA; The Floret Center, Advanced Genomics & Bioinformatics Research Center, Lagos, NigeriaMV
Maria Vliora
Dr. Vliora Maria is a Molecular Biologist with extensive background in molecular biology and integrative physiology. She has previously studied mutations of immunoglobulins in Chronic Lymphocytic Leukemia patients, and ALK mutations and downstream signaling in Neuroblastoma. Dr. Vliora has a PhD in Biomedical Research from University of Thessaly, Greece and University of Brescia, Italy. She has worked on the development of biocompatible/biodegradable bioscaffolds for targeting adipose tissue as well as on potential nanomedical treatments for brain tumors as well as blood malignancies. Her research work is now focusing on environmental influences that can affect human health and on the use of novel biodegradable bio-scaffolds for allografting adipose stem cells in humans. She collaborated with reputable organizations (WHO, ILO) on projects aiming to enhance human health and wellbeing. She now works as a Project Manager on EU funded projects.
Affiliations and expertise
FAME Laboratory, Department of Physical Education and Sport Science, University of Thessaly, Trikala, Greece